This site is part of the Siconnects Division of Sciinov Group

This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.

ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR

Registration

22May
2024

Policy Updates on Surgical Dressings, Wound Dressing Classifications, and More

The Alliance of Wound Care Stakeholders has been busy the last few months with advocating for better policy on a range of issues affecting the wound clinic. Here is a roundup on what we’ve been doing and what results we’ve gotten.Readmore

19 Jan
2024

Bath research used for virtual reality training at Great Western Hospitals NHS Foundation Trust

Doctors and medical students at the NHS Trust are using VR tech to spot the signs and symptoms of sepsis.Readmore

3 May
2024

Cytovale's Diagnostic Test Demonstrates Strong Performance in Rapid Identification of Sepsis Risk, Peer-Review Study Confirms

Large scale study confirms Cytovale's IntelliSep test accurately predicts sepsis risk and severity, aids in appropriate triage and treatment pathways in emergency departmentsReadmore

Dec 18
2023

Advanced Wound Care Management Market Size & Share to Surpass USD 18.2 billion by 2031 | Transparency Market Research, Inc.

Advanced wound care products evolve with innovative technologies, including bioactive dressings and advanced therapies for efficient healing.Readmore

Jun 26
2023

Innovative paper-like, battery-free, AI-enabled sensor for holistic wound monitoring

Low-cost and versatile patch can be customized for different types and sizes of wounds, and provides early warning of adverse conditions to facilitate wound care and managementReadmore

OCT 28
2023

Research Confirms New RecoSMA Laser Successful for Diabetic Foot

A recent study published in the Journal of Wound Care (UK) has shed light on a revolutionary approach to diabetic foot care that promises hope and relief for millions worldwide.Readmore

Mar 06
2023

Wound Care Market Size Is Estimated to Be Valued at USD 30.2 Billion by 2032, at a CAGR of 5.2%

According to Market.us, the estimated value of the global wound care market in terms of revenue was US$ 18.4 billion in 2022 and is anticipated to increase to US$ 30.2 billion by 2032, growing at a CAGR of 5.2% from 2023 to 2032, Owing to Surging Number oReadmore

Jan 26
2023

Advanced Wound Care Market Report 2023: Growth Potential of Emerging Economies Presents Opportunities

The rising prevalence of diseases and ailments that impair the ability to heal wounds as well as rising spending on chronic wounds are some of the factors driving market expansion.Readmore

Dce 18
2023

Advanced Wound Care Management Market Report 2023: Includes Latest Key Development and Market Dynamics by 2030

The global advanced wound care management market is estimated to be valued at US$ 13,197.9 million in 2022 and is expected to exhibit a CAGR of 6.8% by 2030.Readmore

OTC 25
2023

Scientists Develop New Gel That Heals Diabetic Wounds 3x Faster

A first-of-its-kind cell therapy promotes wound healing, improves overall wound health, and lowers risks of recurrence.Readmore

JAN18
2023

LSU HEALTH SCIENCES PHYSICIAN LEAD INVESTIGATOR ON GROUNDBREAKING SEPSIS TEST

Sepsis is the No. 1 cause of death in hospitals and Louisiana leads the country with the highest rate of sepsis mortality, according to the Centers for Disease Control and Prevention. Readmore

SEP12
2023

More people develop sepsis than previously thought, but more survive

Sepsis, also colloquially referred to as blood poisoning, is a serious condition. Just over 3,000 people die with a diagnosis of sepsis in Norwegian hospitals each year.Readmore

July12
2023

New treatments for life-threatening disease sepsis

Due to the increasing resistance to certain antibiotics, the life-threatening condition sepsis is becoming harder to treat. For her PhD project, Leiden pharmacologist Feiyan Liu used mathematical modeling to find out how antibiotics can be used more effecReadmore

July18
2023

Researchers discover novel biomarker for sepsis severity

MUSC researchers have identified a novel biomarker that could change the way sepsis is approached and treated. Sepsis, the leading cause of death in intensive care units, is the body's extreme response to an infection and can lead to organ damage and failReadmore

7 Sep
2023

Magnolia Medical Intensifies Efforts to Combat the Clinical and Economic Risks of Sepsis Misdiagnosis

The company’s goal is to further educate the patient and provider community on the devastating impacts of sepsis misdiagnosis, including its role in antimicrobial resistance.Readmore

28 Mar
2023

Sepsis study to power new antibiotic discoveries

University of Queensland researchers have led a national study on the four main bacteria that cause sepsis, providing new targets for developing antibiotics.Readmore

21 Jun
2023

Swift Medical Partners with the APMA to Improve Diabetic Foot Ulcer and Chronic Wound Care

Swift Medical Partners with The American Podiatric Medical Association (APMA)Readmore

27 Jun
2023

Swift Medical Announces Partnership with Corstrata to Enhance Virtual Wound Care Delivery

Partnership expands access to high-quality wound care in low-resource areasReadmore

18 Jul
2023

REDDRESS LAUNCHES ACTIGRAFT PRO WITH G-CODE REIMBURSEMENT STATUS FOR THE US WOUND CARE MARKET

RedDress oday announced that its ActiGraft PRO product is now commercially available throughout the USReadmore

25May
2023

Kane Biotech Announces FDA 510(k) Clearance for its coactiv+â„¢ Antimicrobial Wound Gel

Kane’s first FDA cleared medical device aims to disrupt global wound care hydrogel marketReadmore

16 Mar
2023

KitoTech Medical Inc. Launches Wound Repair Kit to Stop Bleeding and Close Wounds for Consumers

KitoTech Medical introduces new microMend® 2-in-1 Wound Repair Kit to consumers that includes its microMend® wound closure device and a hemostatic dressing to stop bleeding.Readmore

7 Jul
2023

COLOPLAST ANNOUNCES AGREEMENT TO ACQUIRE KERECIS AND RAISES LONG-TERM GROWTH EXPECTATIONS

Today Coloplast announced the following statement. We’re excited to join the Coloplast family and have their support in becoming the world leader in tissue regeneration. Readmore

AUG 01
2023

International Consensus Document – Wound Care and Skin Tone.

The aim of this meeting and the resulting document was to learn from shared experiences and provide guidance on best practice to improve outcomes for all patients, with a differing range of skin tones.Readmore

AUG 05
2023

White Paper - Wound Balance: Achieving Wound Healing With Confidence

The concept of ‘wound balance’ is multifactorial, encompassing interconnecting issues related to the wound healing process and clinical practice. The wound balance concept aims to integrate various critical parameters which offer continuity, individuaReadmore

Dec 08
2022

Can maternal immunization save more newborns?

I fell in love with medicine in the science lab during middle school in San Jose, California, when I saw how antibiotics prevented bacterial growth in a petri dish. But it was through working with HIV patients as a medical student in Botswana in the mid-1Readmore

22 FEB
2023

First transient electronic bandage speeds healing by 30% Bandage also monitors the healing process, alerting clinicians to issues in real time

Northwestern University researchers have developed a first-of-its-kind small, flexible, stretchable bandage that accelerates healing by delivering electrotherapy directly to the wound site. Readmore

19 APR
2023

The wound dressing that can reveal infection

A nanocellulose wound dressing that can reveal early signs of infection without interfering with the healing process has been developed by researchers at Linköping University.Readmore

24MAR
2023

A novel combination therapy for treating vancomycin-resistant bacterial infections Developed at SMART, the therapy stimulates the host immune system to more effectively clear bacterial infections and accelerate infected wound healing.

Researchers have developed a novel combination therapy using the anticancer agent mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating bacteria that are resistant to the vancomycin, which are also known as vancomycin-resistant EnterocReadmore

1 NOV
2022

Experts pave the way for safer surgery to address global elective waiting lists New research will help to provide safer surgery for thousands of patients around the world – particularly in Low- and Middle-income Countries (LMIC).

Researchers found that routinely changing gloves and instruments just before closing wounds could significantly reduce Surgical Site Infection (SSI) – the world’s most common postoperative complication. Secondly, they tested a new toolkit that can makReadmore

9 MAR
2023

New global AMR collaboration signed with GARDP

The University of Liverpool and the Global Antibiotic Research and Development Partnership (GARDP) have signed a Memorandum of Understanding to collaborate on new projects to address antimicrobial resistance (AMR) for the benefit of public health. Readmore

03 FEB
2023

New strategy to boost NHS access to innovative medical technology

The strategy aims to deliver value for money, using the latest data on the effectiveness of new technology to ensure prices are reasonable for the health system. It will also help build resilient supply chains and ensure the UK is prepared for future pandReadmore

27MAR
2023

SolasCure announces final closing of GBP 10.9m (c. USD 13.3m) Series B fundraise to advance wound care innovation

SOLASCURE Ltd (SolasCure), a biotechnology company developing a hydrogel containing a recombinant enzyme derived from maggots which aims toaccelerate wound debridement, has announced the completion of its GBP 10.9m (c. USD 13.3m)Series B investment round.Readmore

02 FEB
2023

Study of two sepsis interventions finds identical outcomes

In the Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS) trial, investigators compared these two approaches for treating sepsis. Trial results, which were published in the New England Journal of Medicine last week, demonstrated tReadmore

4 MAY
2023

VUMC to coordinate national effort to reduce ARDS, pneumonia, sepsis

Vanderbilt University Medical Center has received a six-year, $31.6 million federal grant to lead a national effort to better understand acute respiratory distress syndrome (ARDS), pneumonia and sepsis, which together kill hundreds of thousands of people Readmore

26 OCT
2022

Machine Learning Enables Diagnosis of Sepsis, the Elusive Global Killer Sepsis Diagnostic Tool Combines Genomic Sequencing With Analysis of Patients’ Immune Response for Remarkable Accuracy

Now, researchers at the Chan Zuckerberg Biohub (CZ Biohub), the Chan Zuckerberg Initiative (CZI), and UC San Francisco (UCSF) have developed a new diagnostic method that applies machine learning to advanced genomics data from both microbe and host – to Readmore

03 FEB
2023

Feinstein Institutes researcher discovers potential therapeutic target for lethal sepsis

Scientists from the Feinstein Institutes for Medical Research recently published in Science Advances the discovery of a novel protein that could be a potential therapeutic target for lethal sepsis.Readmore

25 APR
2023

AI in the ICU

Researchers from Carnegie Mellon University's Human-Computer Interaction Institute (HCII) collaborated with physicians and researchers from the University of Pittsburgh and UPMC to determine if artificial intelligence could help in this decision-making prReadmore

10 JAN
2023

Anticancer drugs: a new hope for sepsis treatment

Research led by the IGC reveals how these drugs limit inflammation, positioning them as potential treatments for sepsis. Readmore

09 Feb
2023

Single Dose of Azithromycin Reduces Maternal Sepsis or Death

A UAB-UNC School of Medicine collaboration found that a single oral dose of the common antibiotic azithromycin reduced the risk of maternal sepsis or death by 33 percent in women who delivered vaginally.Readmore

06 JAN
2023

Asep Inc. signs Letter of Intent for joint venture with Bahrain-based Seaspring W.L.L. for regulatory approval and commercialization of sepsis diagnosis technology

Asep Medical Holdings Inc. (Asep Inc announced that it has recently signed a Letter of Intent (LOI) for a joint venture between Asep Inc. and Seaspring W.L.L (Seaspring). Readmore

13 DEC
2022

Blood clotting research holds hope for sepsis

Thrombosis is a major complication during infection, so drugs are needed that target pathogenic clotting while maintaining vascular integrity and normal clotting process (haemostasis). By selectively targeting S100A8/A9, we aim to target a key pathogenic Readmore

28MAR
2023

Sepsis study to power new antibiotic discoveries

University of Queensland researchers have led a national study on the four main bacteria that cause sepsis, providing new targets for developing antibiotics. Readmore

07 FEB
2023

Standard sepsis-ID systems miss cases in trauma patients

A new automated system identified far more sepsis infections than 2 commonly used methodsReadmore

27MAR
2023

Patients with Septic Shock Benefit from Treatment That Combines Two Steroids

A new study in JAMA Internal Medicine by researchers from Boston University Chobanian & Avedisian School of Medicine shows that patients receiving a combination of hydrocortisone and fludrocortisone had lower death rates and discharge to hospice compared Readmore

Subscribe to our News & Updates